Pharmaceutical Biotechnology
blank LMU M;uuml;nchen Fakultät Chemie und Pharmazie
drucken

Sprachumschaltung
  •  
Navigationspfad


Inhaltsbereich

Publications (since 2000)

  • Zimpel, A., Preiß T., Röder, R., Engelke, H., Ingrisch, M., Peller, M., Rädler, J.O., Wagner, E., Bein, T., Lächelt, U., Wuttke, S.  (2016) Imparting Functionality to MOF Nanoparticles by External Surface Selective Covalent Attachment of Polymers, Chem. Mater., 2016, 28 (10), pp 3318–3326
  • Schaffert, D., Troiber, C., Salcher, E.E., Fröhlich, T., Martin, I., Badgujar, N., Dohmen, C., Edinger, D., Kläger, R., Maiwald, G., Farkasova, K., Seeber, S., Jahn-Hofmann, K., Hadwiger, P., Wagner, E. (2011) Festphasen-basierte Synthese sequenzdefinierter T-, i- und U-Form-Polymere für den pDNA- und siRNA-Transfer. Angew. Chem. 123, 9149 –9152
  • Kircheis, R., and Wagner, E. (2000) Polycation/DNA complexes for in vivo gene delivery. Gene Therapy and Regulation 1, 95-114.
  • Kircheis, R., Wightman, L., Ogris, M., Brunner, S., Kursa, M., Schüller, S., and Wagner, E. (2000) Receptor -mediated gene transfer based on plasmid DNA complexes. Chapter in: Gene Therapy, Bertolotti, Ed.
  • Brunner, S., Sauer, T., Carotta, S., Cotten, M., Saltik, M., and Wagner, E. (2000) Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene Therapy 7, 401-407.
  • van Slooten, M.L., Storm, G., Zoephel, A., Küpcü, Z., Boerman, O., Crommelin, D.J.A., Wagner, E., Kircheis, R. (2000) Liposomes containing interferon-gamma as adjuvant in tumor cell vaccines.  Pharm. Res. 17, 42-48.
  • Ogris, M., Wagner, E., and Steinlein, P. (2000) A versatile assay to study cellular uptake of gene transfer complexes by flow cytometry. Biophys. Biochim. Acta 1474, 237-43.
  • Huber, M., Limat, A., Wagner, E., and Hohl, D. (2000) Efficient in vitro transfection of human keratinocytes with an adenovirus-enhanced receptor-mediated system. J. Invest. Dermatol. 114, 661-666.
  • Kircheis, R., Küpcü, Z., Wallner, G., Rössler, V., Schweighoffer, T., and Wagner, E. (2000) IL-2 gene-modified allogeneic melanoma cell vaccines can induce cross-protection against syngeneic tumor challenge in mice. Cancer Gene Therapy 7, 870-878.
  • Felzmann, T., Buchberger, M., Jechlinger, M., Kircheis, R., Wagner, E., and Gadner, H. (2000) Xenogenization by tetanus toxoid loading into lymphoblastoid cell lines and primary human tumor cells mediated by polycations and liposomes. Cancer Letters 161, 241-250